Literature DB >> 10679738

Lymphocyte subsets and specific T-cell immune response in thalassemia.

K Pattanapanyasat1, C Thepthai, P Lamchiagdhase, S Lerdwana, K Tachavanich, P Thanomsuk, W Wanachiwanawin, S Fucharoen, J M Darden.   

Abstract

Infection is very common in thalassemia and is one of the major causes of death. To date, it is not quite clear why these patients are susceptible to infection. In this study, lymphocyte immunophenotyping for CD3(+) (T-cells), CD3(+)CD4(+) (T-helper/inducer cells), CD3(+)CD8(+) (T-suppressor/cytotoxic cells), CD3(-)CD19(+) (B-cells), and CD3(-)CD16/56(+) (natural killer cells) subsets and expression of the activation antigen CD69 on CD3(+)CD4(+) and CD3(+)CD8(+) T-cells were determined in the whole blood of thalassemia patients, using a three-color flow cytometric technique. Results showed that only splenectomized beta-thalassemia/hemoglobin (Hb) E patients displayed a marked increase in absolute number of all lymphocytes. In addition, splenectomized beta-thalassemia/Hb E showed a significantly lower percentage of CD3(+) cells, with a corresponding increase in CD19(+) cells. These differences, when compared with normal subjects and other thalassemia patients, may be attributed to splenectomy. alpha-thalassemia patients, on the other hand, showed no significant difference from the normal group. While lymphocyte subsets in splenectomized beta-thalassemia/Hb E patients showed an abnormal distribution, T-cell activation in these patients was not different from the activation seen in normal subjects. This implies that thalassemia patients, during the steady state of disease, appear to have normal T-lymphocyte function with only moderate abnormalities of T- and B-lymphocyte subsets. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679738

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  7 in total

1.  Non-functional immunoglobulin G transcripts in a case of hyper-immunoglobulin M syndrome similar to type 4.

Authors:  John M Darlow; Alex M Farrell; David I Stott
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

2.  Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with β-thalassemia major.

Authors:  Asmaa M Zahran; Khaled Saad; Khalid I Elsayh; Mohamd A Alblihed
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

3.  Leukocytes apoptosis and adipocytokines in children with beta thalassemia major.

Authors:  Khalid I Elsayh; Wafaa S Mohammed; Asmaa M Zahran; Khaled Saad
Journal:  Clin Exp Med       Date:  2015-06-09       Impact factor: 3.984

4.  Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease.

Authors:  Weili Bao; Hui Zhong; Deepa Manwani; Ljiljana Vasovic; Joan Uehlinger; Margaret T Lee; Sujit Sheth; Patricia Shi; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2013-06-20       Impact factor: 10.047

5.  Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders.

Authors:  Vichai Atichartakarn; Khanchit Likittanasombat; Suporn Chuncharunee; Pakorn Chandanamattha; Surapon Worapongpaiboon; Pantep Angchaisuksiri; Katcharin Aryurachai
Journal:  Int J Hematol       Date:  2003-08       Impact factor: 2.490

6.  Correlations between Iron Load and CD4 in Adult Transfusion-Dependent Beta Thalassemia.

Authors:  Tubagus Djumhana Atmakusuma; Ralph Girson; Sukamto Koesnoe
Journal:  Anemia       Date:  2021-06-17

7.  Seroprovalence of herpes simplex1, 2 IgG antibodies in patients with beta thalassemia in a major tertiary care hospital located in Yazd, Iran.

Authors:  A Atefi; F Binesh; A Hashemi; A Atefi; Mm Aminorroaya
Journal:  Iran J Ped Hematol Oncol       Date:  2014-04-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.